FDA removes in-person dispensing requirement for abortion medication

FDA removes in-person dispensing requirement for abortion medication

Source: 
RAPS.org
snippet: 

The US Food and Drug Administration (FDA) is modifying the shared Risk Evaluation and Mitigation Strategy (REMS) for mifepristone products to allow women to continue to access the abortion medication through the mail via a certified prescriber.